Business

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

BROOMFIELD, Colo., May 28, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today issued the following statement in response to the press release issued by Echo Lake Capital and its offer to acquire the Company for $4.00 per share in cash and contingent value rights: Acl

articleAclarion, Inc.May 28, 20264/company/aclarion-inc/news/aclarion-inc-comments-on-echo-lake-capitals-letter-and-unsolicited-proposal
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

About this update from Aclarion, Inc.

[{"type":"image","alt":"Aclarion, Inc.","displaySize":"","headline":null,"caption":"Aclarion, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":140,"height":83,"url":"https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/EohHW56rTadgndYE9QH9_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEyNQ--/https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf","width":140,"height":83},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/EohHW56rTadgndYE9QH9_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEyNQ--/https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf","width":140,"height":83}},"lazy":false},{"type":"text","content":"BROOMFIELD, Colo., May 28, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today issued the following statement in response to the press release issued by Echo Lake Capital and its offer to acquire the Company for $4.00 per share in cash and contingent value rights:","length":496,"tagName":"p"},{"type":"text","content":"Aclarion's Board of Directors and management team are committed to acting in the best interests of the Company and all of its shareholders. We regularly review our strategic priorities and evaluate opportunities to enhance value for all stakeholders. To that end, the Board of Directors will carefully review and evaluate Echo Lake’s proposal to determine the course of action that it believes is in the best interests of the Company and its shareholders.","length":459,"tagName":"p"},{"type":"text","content":"The Board authorized a share repurchase program underscoring our conviction that Aclarion's current market valuation does not fully reflect the strength of our platform or the long-term opportunity ahead. This action also reflects our commitment to deploying capital in ways that serve the interests of all shareholders while continuing to invest in our business.","length":367,"tagName":"p"},{"type":"text","content":"The Company notes that the Echo Lake communication contains numerous assertions regarding governance and other matters that lack important context...

More updates from Aclarion, Inc.

Aclarion, IncEcho Lake CapitalEcho LakeBoard of Directorschronic low back painThe CompanyCompanyaugmented intelligenceforward-looking statementsshareholders